AFRM vs ARQT · P/E 590, rev $3.22B vs rev $196.5M
Affirm Holdings Inc (AFRM) versus Arcutis Biotherapeutics Inc (ARQT) — a side-by-side from cached financials, not a winner call.
Affirm Holdings Inc (AFRM) is a software - infrastructure company listed on US.
Arcutis Biotherapeutics Inc (ARQT) is a biotechnology company listed on US.
Latest reported AFRM revenue for 2025-06-30 was $3.22B. Net income was $52.2M. Revenue was up 38.8% from 2024-06-30 to 2025-06-30. AFRM currently screens at market cap $28.80B and trailing P/E 589.7.
Latest reported ARQT revenue for 2024-12-31 was $196.5M. Net income was -$140.0M. Revenue was up 229.7% from 2023-12-31 to 2024-12-31. ARQT currently screens at market cap $1.64B.
AFRM currently screens at market cap $28.80B and trailing P/E 589.7. ARQT currently screens at market cap $1.64B.
Not investment advice. Open the AFRM and ARQT stock pages for the full models.
Not investment advice.